olivLaw · US equity research
Buda Juice, Inc. BUDA
Beverages · SIC 2080 · Vertical: Beverages (SIC 2080)
Buda Juice, Inc. (NYSE American: BUDA) produces cold-crafted, never heat-treated citrus juices and lemonades that it sells to large supermarket chains under its UltraFresh™ category. The company listed in January 2026, and by the end of the first half of 2026 its cash position was far larger than a year earlier, which gives it room to expand geographically. For the profile, the key issues are its dependence on a single customer and a gross margin that has recently declined.
At the close of 04 Nov 2026, Buda Juice, Inc. (BUDA) stock was 6.62 USD (−4.06% on the day), with market capitalisation 83.2 m USD, P/E 33.1 on diluted EPS of 0.20 USD over the last 12 months, beta -0.27, 52-week range 6.60–10.86 USD. Latest reported quarter (Q2 2026): revenue of 4.5 m USD (+26.4% YoY), net income of 470.0 k USD (−59.8% YoY), diluted EPS 0.04 USD.
Data as of · AI analysis dated · Source: SEC filings and closing prices, computed by olivLaw.
Price history
Loading chart…
Technical reading
- RSI (14)
- 38.6
- weak (30–45)
- Bollinger (20, 2)
- 6.40 – 7.89
- in the lower half of the band · %B 0.15 · band width 21.0%
- SMA 50 / 200
- 7.58 / 8.76
- downtrend (price < SMA50 < SMA200)
- MACD (12, 26, 9)
- -0.25 / -0.24
- MACD below signal
Indicators describe past prices; on their own they do not predict direction. On our history the RSI ≤ 40 filter added no return (see the signals methodology).
Performance
| Company | S&P 500 | vs S&P 500 | Vertical median | |
|---|---|---|---|---|
| 1 month | −8.1% | −1.1% | −7.0 pp | — |
| 3 months | −18.3% | −0.5% | −17.8 pp | — |
| 6 months | −28.7% | +4.4% | −33.1 pp | — |
| Year to date | unavailable | +12.3% | unavailable | — |
| 1 year | unavailable | +13.5% | unavailable | +6.6% |
| 3 years | unavailable | +76.4% | unavailable | −30.5% |
| 5 years | unavailable | +63.7% | unavailable | — |
Price returns, dividends excluded.
Quarterly results
Latest quarter: Q2 2026 · 30 Jun 2026
Quarterly margins
Quarterly statements · USD
| Fiscal year | Q1 '25 | Q2 '25 | Q1 '26 | Q2 '26 |
|---|---|---|---|---|
| Revenue | 3.0 m | 3.6 m | 3.5 m | 4.5 m |
| Cost of revenue | 1.6 m | 1.9 m | 2.1 m | 2.9 m |
| Gross profit | 1.3 m | 1.7 m | 1.4 m | 1.7 m |
| SG&A | 407.0 k | 378.0 k | 663.0 k | 1.1 m |
| Operating income | 803.0 k | 1.1 m | 593.0 k | 444.0 k |
| Depreciation & amortisation | 87.0 k | 69.0 k ≈ | 57.0 k | 63.0 k ≈ |
| Pre-tax income | 816.0 k | 1.2 m | 747.0 k | 599.0 k |
| Income tax | 9.0 k | 9.0 k | 359.0 k | 129.0 k |
| Net income | 807.0 k | 1.2 m | 388.0 k | 470.0 k |
| Diluted EPS | — | — | 0.03 | 0.04 |
| Operating cash flow | 904.0 k | 929.0 k ≈ | 1.3 m | -365.0 k ≈ |
| Capex | 139.0 k | — | 218.0 k | -118.0 k ≈ |
≈ derived quarter (cumulative difference / share-days average)
E/P over time
E/P = trailing-12-month diluted EPS / price at quarter end. E/P is the inverse of P/E and stays defined when earnings are negative.
Fiscal years
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 11.3 m | 12.6 m |
| Revenue YoY | unavailable | +11.8% |
| Net income | 3.6 m | 3.5 m |
| Net income YoY | unavailable | −1.1% |
| Diluted EPS | 0.20 | 0.20 |
| Diluted EPS YoY | unavailable | 0.0% |
| net % | 31.7% | 28.0% |
| Free cash flow | 3.3 m | 2.9 m |
Reported results vs expectations
Loading…
Balance sheet & financial health
Fiscal year 2025 · 31 Dec 2025
- Cash
- 1.8 m USD
- Financial debt
- 647.0 k USD
- Net debt
- -1.2 m USD
- Equity
- 3.7 m USD
- Total assets
- 5.0 m USD
- Debt / equity
- 0.17x
- Current ratio
- 5.50x
- ROE
- 102.5%
- ROA
- 81.2%
- FCF margin
- 23.0%
Financial statements (source on every figure)
Revenue and net income (USD)
Margins
Income statement · USD
| Line | 2024 | 2025 | Source (latest year) |
|---|---|---|---|
| Revenue | 11.3 m | 12.6 m | SEC (XBRL)· 26 Mar 2026verified |
| Cost of revenue | 6.1 m | 7.0 m | SEC (XBRL)· 26 Mar 2026verified |
| Gross profit | 5.2 m | 5.6 m | SEC (XBRL)· 26 Mar 2026verified |
| SG&A | 1.3 m | 1.7 m | SEC (XBRL)· 26 Mar 2026verified |
| Operating income | 3.4 m | 3.4 m | SEC (XBRL)· 26 Mar 2026verified |
| Depreciation & amortisation | 274.0 k | 239.0 k | SEC (XBRL)· 26 Mar 2026verified |
| EBITDA | 3.7 m ≈ | 3.7 m ≈ | SEC (XBRL)· 26 Mar 2026derived |
| Income tax | — | 0 | SEC (XBRL)· 26 Mar 2026verified |
| Net income | 3.6 m | 3.5 m | SEC (XBRL)· 26 Mar 2026verified |
| Diluted EPS | 0.20 | 0.20 | SEC (XBRL)· 26 Mar 2026verified |
| Weighted average diluted shares | 14.0 k | 14.0 k | SEC (XBRL)· 26 Mar 2026verified |
≈ computed by olivLaw from the reported lines of the same year: Operating income + Depreciation & amortisation.
Balance sheet · USD
| Line | 2024 | 2025 | Source (latest year) |
|---|---|---|---|
| Cash | 1.9 m | 1.8 m | SEC (XBRL)· 26 Mar 2026verified |
| Receivables | 395.0 k | 386.0 k | SEC (XBRL)· 26 Mar 2026verified |
| Inventories | 374.0 k | 348.0 k | SEC (XBRL)· 26 Mar 2026verified |
| Current assets | 2.7 m | 3.2 m | SEC (XBRL)· 26 Mar 2026verified |
| Property, plant & equipment, net | 969.0 k | 976.0 k | SEC (XBRL)· 26 Mar 2026verified |
| Total assets | 3.7 m | 5.0 m | SEC (XBRL)· 26 Mar 2026verified |
| Accounts payable | 449.0 k | 289.0 k | SEC (XBRL)· 26 Mar 2026verified |
| Long-term debt | — | 647.0 k | SEC (XBRL)· 14 May 2026verified |
| Current liabilities | 575.0 k | 585.0 k | SEC (XBRL)· 26 Mar 2026verified |
| Total liabilities | 575.0 k | 1.2 m | SEC (XBRL)· 26 Mar 2026verified |
| Equity | 3.2 m † | 3.7 m † | SEC (XBRL)· 26 Mar 2026verified |
† equity attributable to the parent's shareholders: in these years the issuer no longer reports the total including non-controlling interests.
Cash flow · USD
| Line | 2024 | 2025 | Source (latest year) |
|---|---|---|---|
| Operating cash flow | 4.0 m | 3.2 m | SEC (XBRL)· 26 Mar 2026verified |
| Capex | 684.0 k | 246.0 k | SEC (XBRL)· 26 Mar 2026verified |
| Free cash flow | 3.3 m ≈ | 2.9 m ≈ | SEC (XBRL)· 26 Mar 2026derived |
| Investing cash flow | -684.0 k | -246.0 k | SEC (XBRL)· 26 Mar 2026verified |
| Financing cash flow | -2.8 m | -3.0 m | SEC (XBRL)· 26 Mar 2026verified |
≈ computed by olivLaw from the reported lines of the same year: Operating cash flow − Capex.
Computed indicators
Growth
Profitability
Returns
Balance sheet
Liquidity
Cash
Efficiency
Market and valuation
1 indicators that do not apply to the sector.
Valuation
olivLaw classification
Score: 69 / 100
A scoring methodology on indicators and valuation, not investment advice.
Closing price
04 Nov 2026Source: olivLaw, closing series
Market cap: 83.2 m USD
Key indicators
Coverage and freshness
Score by group
- Balance sheet100
- Quality86
- Valuation40
Estimated value range
The combined range = the median of the valid methods' low, central and high values; it is not a probability interval and does not cover every result. Envelope of all methods: 3.67 – 6.82 USD.
Valuation assumptions are editorial choices, not measured; beta is not measured.
Method ranges (USD per share)
— — Mid · ▏ Price
Valuation methods
- DCF (discounted cash flow)unavailable · input data missing
- Peers: EV/EBITDA3.89 – 6.82 (Mid 4.86)5 companies used · median multiple 15.7x · quartiles 11.3x – 24.7xBF-A, KO, PEP, PRMB, WEST
- Peers: P/E3.67 – 6.09 (Mid 4.66)6 companies used · median multiple 24.3x · quartiles 19.1x – 31.7xBF-A, COCO, KDP, KO, PEP, YHC
- Dividend discount (DDM)unavailable · the company pays no dividend: a dividend model needs an explicit initiation assumption
Classification (SIC) comparables group by industry code, not by economic activity; the direct group is an editorial selection by activity. Members' multiples are on their own trailing twelve months, at their own latest close.
Assumptions (illustrative, editorial)
- Risk-free rate
- 4.3%
- Equity risk premium
- 5.0%
- Beta (default)
- 1.00
- Cost of equity
- 9.3%
- Terminal growth
- 2.5%
Factor scorecard
Neutral profile · Score 69/100
| Factor | Value | Score | Weight used |
|---|---|---|---|
| ROIC · Quality | 59.7% | 100 (vs peers) | 16% |
| Net margin · Quality | 17.1% | 76 (vs peers) | 9% |
| FCF conversion · Quality | 80.0% | 71 (on a fixed band) | 9% |
| Revenue CAGR 3Y · Growth | unavailable | unavailable | — |
| EPS CAGR 3Y · Growth | unavailable | unavailable | — |
| Net debt / EBITDA · Balance sheet | -6.6x | 100 (vs peers) | 16% |
| Interest coverage · Balance sheet | unavailable | unavailable | — |
| Current ratio · Balance sheet | 15.2x | 100 (on a fixed band) | 6% |
| P/E (TTM) · Valuation | 34.5x | 38 (vs peers) | 16% |
| EV/EBITDA · Valuation | 23.8x | 50 (vs peers) | 16% |
| FCF yield · Valuation | 2.3% | 29 (on a fixed band) | 13% |
| Shareholder yield (distributions) · Returns | unavailable | unavailable | — |
| Payout ratio (FCF) · Returns | unavailable | unavailable | — |
Factors without a value were dropped; the remaining weights were renormalised.
Score groups
- Balance sheet100/100 · 2/3 factors with a value
- Growth· partialunavailable · 0/2 factors with a value
- Quality86/100 · 3/3 factors with a value
- Returns· partialunavailable · 0/2 factors with a value
- Valuation40/100 · 3/3 factors with a value
A «partial» group is computed from under half of its weight or from one factor: it is not a full assessment of the group.
Memo
BUDA JUICE, INC. (BUDA). Latest full fiscal year: 2025; data up to 2026-06-30.
Figures computed from the financial statements: revenue 12.6 m USD in 2025; YoY growth 11.8%; net margin 17.1%; ROE 19.3%; net debt/EBITDA -6.6x.
The estimated value range is 3.78–6.46 USD per share (median of 2 methods, agreement: same basis (multiples on one peer group, not independent confirmations)); assumptions are illustrative. Against the central value of 4.76 USD, the price of 6.62 USD leaves a potential of -28.1% (value / price − 1) and a margin of safety of -39.1% (1 − price / value). The range is the median of the methods' low, central and high values, not a probability interval.
olivLaw score 69/100, methodological classification: neutral profile (score, margin of safety and method agreement together; not a judgement of the right price). Groups assessed only in part: growth, returns. Not investment advice.
Text generated deterministically from the figures shown; no language model. Not investment advice.
What supports the thesis
- ROIC: 59.7%
- Net margin: 17.1%
- FCF conversion: 80.0%
- Net debt / EBITDA: -6.6x
- Current ratio: 15.2x
What contradicts it
- FCF yield: 2.3%
- The price is above the estimated value range
Not assessed (insufficient data or a ratio without meaning): Revenue CAGR 3Y, EPS CAGR 3Y, Interest coverage, Shareholder yield (distributions), Payout ratio (FCF).
Versus the vertical median
Beverages (SIC 2080) · same industry (4-digit SIC) · compared with 17 companies
Multiples and returns vs the median
Price rebased to 100 (monthly, 5 years)
Companies in the vertical
| Market cap | P/E | ROE | Net margin | Revenue YoY | 1A / 3A | |
|---|---|---|---|---|---|---|
| KOCoca Cola Co | 412.1 bn | 28.2 | 42.6% | 28.7% | +1.9% | +31% / +64% |
| DEODIAGEO plc | 237.6 bn | 92.4 | 24.0% | 9.1% | +0.3% | +7% / −30% |
| PEPPepsico Inc | 194.1 bn | 18.7 | 50.1% | 10.8% | +2.3% | −4% / −15% |
| KDPKeurig Dr Pepper Inc. | 50.1 bn | 37.2 | 5.7% | 7.1% | +8.2% | +32% / +17% |
| BF-ABrown Forman Corp | 14.9 bn | 20.3 | 18.1% | 18.4% | −1.2% | +10% / −48% |
| PRMBPrimo Brands Corp | 7.6 bn | 79.4 | 3.2% | 1.5% | +29.3% | +34% / +46% |
| COCOThe Vita Coco Company, Inc. | 3.7 bn | 32.9 | 32.0% | 15.7% | +18.2% | +23% / +133% |
| WESTWestrock Coffee Company | 1.0 bn | — | — | -4.9% | +39.8% | +138% / +13% |
| BUDABuda Juice, Inc. | 83.2 m | 34.5 | 19.3% | 17.1% | +11.8% | unavailable / unavailable |
| SRXHSRX Global Inc. | 18.0 m | — | -70.8% | -254.8% | −81.3% | −96% / −100% |
| WVVIWillamette Valley Vineyards, Inc. | 8.3 m | — | -3.3% | -5.9% | −6.5% | −37% / −68% |
| YHCLQR House Inc. | 2.9 m | 0.2 | -88.2% | -1,589.2% | −37.4% | −98% / −100% |
| IPSTIp Strategy Holdings, Inc. | 2.3 m | — | -2,713.2% | -2,064.0% | +20.4% | −98% / unavailable |
| EDVAEndovia Health Sciences, Inc. | 1.2 m | — | — | -53,856.5% | −90.9% | −96% / −100% |
| BRCCBRC Inc. | 903.4 k | — | -14.2% | -1.5% | +1.7% | −23% / −77% |
| IBGInnovation Beverage Group Limited | 593.4 k | — | — | -223.4% | −5.1% | −94% / unavailable |
| STZConstellation Brands, Inc. | — | — | 23.9% | 20.9% | −10.5% | +7% / −40% |
| ABEVAmbev S.A. | — | — | 16.6% | 17.6% | −1.4% | +9% / +1% |
1- and 3-year price returns: for BUDA from daily closes (the same as the performance table), for the other companies from month-end closes.
olivLaw engine forecast
The world engine ran after the company's latest material disclosure. Probabilities are of TOUCHING a level within the horizon (not closing there) and sit next to the random walk (p_rw), the no-information benchmark.
The engine has no published run for this company yet.
Valuation scenarios (editable assumptions)
Illustrative scenarios
Illustrative: not forecasts and without probabilities. Each case is one coherent set of assumptions, computed on today's figures.
Estimated price (USD)
| Estimated price | Bear | Base | Bull |
|---|---|---|---|
| 1 years | 4.20 Total return -37% · Per year -37% | 7.40 Total return 12% · Per year 12% | 11.12 Total return 68% · Per year 68% |
| 3 years | 4.70 Total return -29% · Per year -11% | 9.26 Total return 40% · Per year 12% | 15.18 Total return 129% · Per year 32% |
| 5 years | 5.26 Total return -21% · Per year -4% | 11.58 Total return 75% · Per year 12% | 20.72 Total return 213% · Per year 26% |
- Exit P/E± 2.32
- Net margin± 1.62
- Annual revenue growth± 1.24
- Annual dilution± 0.14
AI analysis
AI-generatedAI-generated analysis (Claude) from cited public sources; it may contain errors. Not investment advice. As of 27 Oct 2026 · Model: claude-haiku-5-5.
In brief
Buda Juice, Inc. (NYSE American: BUDA) produces cold-crafted, never heat-treated citrus juices and lemonades that it sells to large supermarket chains under its UltraFresh™ category. The company listed in January 2026, and by the end of the first half of 2026 its cash position was far larger than a year earlier, which gives it room to expand geographically. For the profile, the key issues are its dependence on a single customer and a gross margin that has recently declined.
SWOT
Strengths
- The UltraFresh™ positioning is differentiated, and the continuous cold chain and SQF certification create a real technical barrier. The asset-light model and grower relationships allow growth with moderate investment.
- The company holds substantial cash after the January 2026 public offering, giving it flexibility to expand regional hubs. Its leadership has long-standing relationships with major US retailers.
- The launch in several hundred Walmart stores shows the product can be scaled beyond its original market, a practical proof of multi-state distribution capability.
Weaknesses
- Dependence on a single customer, which accounts for almost all sales, makes revenue very sensitive to one trading partner's decisions 1.
- Gross margin fell in early 2026 because of fruit and refrigerated freight costs, and citrus prices are hard to control 23.
- The company operates a single production plant with no redundant infrastructure, so a cold-chain interruption could affect the whole business 1.
Opportunities
- The South Carolina and Arizona/Nevada hubs could open large eastern and western markets if completed on schedule 1.
- Diversifying customers, including national chains and private-label lines, could reduce dependence on one commercial partner 1.
- If consumer interest in fresh, minimally processed products keeps growing, the company could extend its range and bring new formats to shelves.
Threats
- Large beverage brands could copy the perceived look and quality of the products and use marketing power to win shelf space 1.
- Rising refrigerated freight costs and fuel volatility could compress margins further 23.
- Any food safety incident or cold-chain failure could damage the brand, which depends on the perception of freshness 1.
Risks
- Dependence on a single customerhigh
Almost all revenue comes from one customer. Losing this partner or a drop in its orders could seriously affect revenue and cash flow 1.
- Pressure on gross marginhigh
Costs of citrus, limes and refrigerated transport reduced gross margin in 2025 and in the first half of 2026. If these costs stay high, profitability could decline further 23.
- Concentrated production infrastructuremedium
The company has one plant and no redundancy. A cooling equipment failure, a power outage or a natural disaster could halt production and cause product losses 1.
- Competition from large producersmedium
Large beverage companies can copy fresh lines and use superior marketing resources, which could limit growth and put pressure on prices 1.
- Geographic expansion risksmedium
The South Carolina and Arizona/Nevada hubs are at an early stage. Delays in completion or operation below expected efficiency could slow the expansion 1.
Investment thesis
What would need to be true (bull case)
- If Buda Juice turns the Walmart launch into a stable presence across several states, the company could demonstrate that the UltraFresh™ model can scale nationally 3.
- Cash remaining after the public offering gives room to invest in regional hubs without depending immediately on external financing 2.
- If customer diversification advances and gross margin returns to earlier levels, profitability could become more predictable.
What would break the thesis
- Near-total dependence on one customer makes revenue vulnerable to a single commercial decision by that partner 1.
- Gross margin fell in early 2026 and net profit declined from the prior year, showing that scaling has not automatically translated into higher earnings 23.
- The company has a limited operating history and a single plant, so the execution of geographic expansion remains unproven at scale 1.
What to watch
- Development of gross margin and the costs of citrus and refrigerated transportQ3 2026
- Status of the South Carolina hub, planned for completion in 20262026
- Status of the Arizona/Nevada hub, planned for completion in 20272027
Products, market & competition
AI-generatedAI-generated analysis (Claude) from cited public sources; it may contain errors. Not investment advice. As of 27 Oct 2026 · Model: claude-haiku-5-5.
The business
The model is B2B: retailers receive a turnkey solution without investing in cold infrastructure or trained staff for in-store juicing. The company shifted in 2020 from its own stores to direct distribution through large retail chains 1. Its legal form changed on January 1, 2026, when Buda Juice LLC of Texas became Buda Juice, Inc., a Delaware corporation 1.
Segments
Buda Juice (organic)
The premium line includes 2 oz organic wellness shots sold in 2-pack and 6-pack glass bottle configurations 1. It is the segment that supports the company's positioning as an organic, high-quality brand.
Market context
The company positions itself in the US fruit juice market, which the sources it cites describe as large and growing, but the documents provided give no verified market size figure, so no such value is presented here. Buda Juice sells mainly in Texas and neighboring states, and its national presence is still at an early stage.
The refrigerated fresh segment is the most relevant for the company, since its products compete for space in the fresh section, where retailers look for traffic and fast rotation. If the trend toward products without heat treatment strengthens, the company could benefit from its positioning, but this depends on consumer adoption and shelf space availability 1.
Trends
- Demand for fresh and minimally processed productstailwind
Consumers increasingly look for products perceived as fresh, and retailers see refrigerated products as drivers of store traffic. The UltraFresh™ model rests on exactly this demand 1.
- Pressure from fruit and fuel costsheadwind
Costs for citrus and limes rose in 2025 and in the first quarter of 2026, and diesel price volatility raised refrigerated freight costs. These costs reduced gross margin in those periods 23.
- Geographic distribution expansionmixed
The May 2026 Walmart launch and the planned hubs in South Carolina and Arizona/Nevada show the company trying to move beyond the Texas market. Success depends on keeping cold-chain quality over longer distances 13.
- Costs of being a public companyheadwind
After the listing, administrative expenses and stock-based compensation rose significantly, which reduced operating income in the early months of 2026 2.
Competitive position
The company competes with large beverage manufacturers, traditional juice brands launching fresh or cold-pressed lines, and emerging functional beverage businesses in kombucha, smoothies, flavored waters and plant-based drinks 1. Many rivals have larger marketing budgets, stronger distributor ties and can control their own production or logistics.
The company's stated advantage is its continuous cold chain from source to shelf and its relationships with citrus growers, both difficult to replicate quickly. If large brands were to copy product quality and image, Buda Juice could lose shelf space and sales velocity 1.
- Tropicana (PepsiCo)PEP
A major orange juice brand competing for fresh-section shelf space and the premium segment; the source refers to large beverage makers in general and does not name this company.
- Large multinational beverage makers
Companies with significant resources, broad distribution and the ability to launch fresh or functional lines quickly, cited in company filings as the main competitive pressure.
- Traditional juice brands launching cold-pressed lines
Established producers using scale and in-store presence to introduce fresh alternatives, with a risk of reducing shelf space for Buda Juice.
- Functional and wellness beverage producers
Emerging companies in kombucha, smoothies, flavored waters and plant-based drinks competing for health-oriented consumers.
Links, dependencies and risks
Who the company is tied to, from its own SEC filings (customers, suppliers, production, partners, competitors, countries, regulation), from the 5 %+ holders' statements (13D/13G) and from what other companies say about it. Click a node for its evidence; on a listed company the graph moves to it.
Loading the links…
News & filings
In the press
- Daniel Buda: Finanțările europene pentru proiectele energetice trebuie să includă investiții în securitate cibernetică; deficitul de specialiști, o vulnerabilitate majoră a UEFinancial Intelligence (RO) · 29 Oct 2026 · RO
- Buda: Fermierii români trebuie să primească garanții că activitatea lor nu va fi afectată de situația din Marea NeagrăAgerpres · 21 Oct 2026 · RO
- MEP Daniel Buda: PNL to decide on backing Niculescu Gov't after reviewing programme - StiripesurseSurge — Google News · 06 Oct 2026 · RO
- În maximum o lună vor fi deblocate exporturile de oi vaccinate către ţările din afara UE, spune europarlamentarul Daniel BudaDigi24 · 16 Sept 2026 · RO
- Daniel Buda: În maximum o lună vor fi deblocate exporturile de animale vaccinate către țările terțeFinancial Intelligence (RO) · 16 Sept 2026 · RO
- Daniel Buda: Exporturile de oi către țări terțe ar putea fi deblocate în maximum o lunăCursDeGuvernare.ro · 16 Sept 2026 · RO
- Eurodeputatul PNL Daniel Buda: „Nu vom vota niciun guvern din care să facă parte vreun membru PSD sau cineva care să aibă legătură cu PSD” - PRESShubSurge — Google News · 16 Sept 2026 · RO
- Eurodeputatul PNL Daniel Buda: „Nu vom vota niciun guvern din care să facă parte vreun membru PSD sau cineva care să aibă legătură cu PSD” - presshub.roSurge — Google News · 16 Sept 2026 · RO
- Exporturile de animale vaccinate ar putea fi deblocate în maximum o lună, anunță eurodeputatul Daniel Buda - Stirile ProTVSurge — Google News · 16 Sept 2026 · RO
- Daniel Buda: Exports of vaccinated animals to third countries will be unblocked within a maximum of one month - StiripesurseSurge — Google News · 16 Sept 2026 · RO
- Daniel Buda: Exports of vaccinated animals to third countries will be unblocked within a maximum of one month - StiripesurseSurge — Google News · 16 Sept 2026 · RO
- Eurodeputatul Daniel Buda (PNL): În maximum o lună vor fi deblocate exporturile de animale vaccinate către ţările terţeG4Media · 16 Sept 2026 · RO
- Daniel Buda: În maximum o lună vor fi deblocate exporturile de animale vaccinate către țările terțe - AgerpresAgerpres · 16 Sept 2026 · RO
- Europarlamentarul Daniel Buda (PNL): Exporturile de ovine s-ar putea debloca în maximum o lună / Comisia Europeană a înțeles situația României / Ne-a oferit gratuit peste 1,3 milioane de doze de vaccinG4Media · 16 Sept 2026 · RO
- PNL închide complet ușa pentru PSD. Daniel Buda: „Nu vom susține un guvern controlat de PSD”Mediafax · 20 Aug 2026 · RO
- Eurodeputatul Daniel Buda: Am transmis o scrisoare către președinta Comisiei Europene prin care solicităm un răspuns adecvat în urma incidentelor repetate cu drone produse pe teritoriul RomânieiG4Media · 26 Jul 2026 · RO
- Liberalul Buda le răspunde PSD-iștilor invocându-l pe Zegrean: „Luați o lecție de drept constituțional. Cu lămâie! Bolojan poate rămâne la Palatul Victoria până în 2028G4Media · 06 Jul 2026 · RO
- Daniel Buda este noul şef al Delegaţiei României din grupul PPE. Europarlamentarul PNL îl înlocuiește pe Rareş BogdanDigi24 · 01 Jul 2026 · RO
- Europarlamentarul PNL Daniel Buda: În instituțiile europene s-au aprins deja semnalele de alarmă. Când un stat începe să fie asociat cu forțe politice percepute ca fiind ostile proiectului european și intereselor strategice ale UE, consecințele nu întârzie să aparăG4Media · 22 Jun 2026 · RO
- Fermele zootehnice ar trebui elimnate din Directiva privind Emisiile Industriale/ Daniel Buda (europarlamentar): „Un fermier care produce hrană pentru Europa nu trebuie tratat ca un operator industrial”G4Media · 14 Jun 2026 · RO
SEC filings
- Quarterly report14 Aug 2026
- Current report15 May 2026Results of operations · Financial statements and exhibits
- Quarterly report14 May 2026
- Annual report26 Mar 2026
- Current report22 Jan 2026Regulation FD disclosure · Other events · Financial statements and exhibits
- Current report09 Jan 2026Material agreement · Departure or appointment of officers · Regulation FD disclosure · Financial statements and exhibits
Sources
- [1] Form 10-K, fiscal year ended 2025-12-31 · SEC / Buda Juice, Inc. · 26 Mar 2026
- [2] Form 10-Q, quarter ended 2026-06-30 · SEC / Buda Juice, Inc. · 14 Aug 2026
- [3] Form 8-K, results release (exhibit 99.1) · SEC / Buda Juice, Inc. · 15 May 2026
Figures computed by olivLaw from SEC filings and closing prices; the qualitative analysis is AI-generated from cited sources. Not investment advice.